Par8O

J & J Innovation Center is a cutting-edge research and development facility based in Cambridge, MA. Specializing in fostering innovation and collaboration, the center provides a dynamic environment for forward-thinking professionals to explore new ideas and technologies. With a focus on driving advancements in various industries, J & J Innovation Center serves as a hub for creative thinkers to connect, experiment, and push the boundaries of what is possible. The center's mission is to support and accelerate the development of groundbreaking solutions that have the potential to make a significant impact on society. Generated from their business information

Leap Therapeutics, based in Cambridge, MA, is dedicated to developing targeted and immuno-oncology therapeutics, with a focus on innovative treatments for various cancer types, including gastric, colorectal, and gynecologic cancers. Their lead candidate, DKN-01, is a humanized monoclonal antibody that targets the Dickkopf-1 (DKK1) protein and is currently in clinical development for patients with DKK1-expressing tumors. In addition to DKN-01, Leap Therapeutics is advancing FL-301, which targets Claudin18.2 for gastric and pancreatic cancers, and FL-501, a preclinical candidate that targets the growth and differentiation factor 15 (GDF-15) protein. The company is committed to understanding tumor expression and discovering new therapeutic targets and combinations to improve cancer treatment outcomes. Generated from the website